Rome-based Angelini Pharma has inked a multi-year deal with Massachusetts biotech Quiver Bioscience that is designed to advance novel therapies for genetic epilepsies and could garner up to $120 ...

Quiver Distribution has announced the first details of the upcoming third installment of its popular R-rated action franchise ...

Angelini Pharma, part of the privately owned Angelini Industries, and Quiver Bioscience ("Quiver"), a discovery technology and therapeutics company advancing programs for the treatment of central ...

CAMBRIDGE, Mass., July 01, 2025--(BUSINESS WIRE)--Quiver Bioscience ("Quiver"), a discovery technology and therapeutics company advancing programs for treatment of serious central nervous system (CNS) ...

Quiver has nabbed North American rights to Uwe Boll's latest movie, the action thriller "Citizen Vigilante," starring Armie Hammer. Written, directed and produced by Boll and executive produced by ...

Angelini Pharma and Quiver Bioscience enter research collaboration and licensing pact to discover and advance novel therapeutics for genetic epilepsies: Rome Wednesday, February 2 ...